NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer

ABSTRACT: Evaluate the clinical safety and feasibility of NKG2D CAR-T administrated by hepatic artery transfusion for patients with previously treated liver metastatic colorectal cancer.

DISEASE(S): Refractory Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2405312 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR